SCPHARMACEUTICALS INC's ticker is SCPH and the CUSIP is 810648105. A total of 76 filers reported holding SCPHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.03 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $148,765 | -85.0% | 20,894 | -80.9% | 0.00% | – |
| Q1 2023 | $989,827 | +423.8% | 109,132 | +314.1% | 0.00% | – |
| Q4 2022 | $188,965 | -73.2% | 26,355 | -77.1% | 0.00% | – |
| Q2 2021 | $704,000 | -83.7% | 115,264 | -82.2% | 0.00% | -100.0% |
| Q1 2021 | $4,314,000 | +1954.3% | 648,770 | +1531.4% | 0.00% | – |
| Q4 2020 | $210,000 | -20.5% | 39,768 | +12.0% | 0.00% | – |
| Q3 2020 | $264,000 | +88.6% | 35,494 | +86.7% | 0.00% | – |
| Q2 2020 | $140,000 | +10.2% | 19,012 | +10.9% | 0.00% | – |
| Q1 2020 | $127,000 | +101.6% | 17,148 | +59.7% | 0.00% | – |
| Q3 2018 | $63,000 | -72.4% | 10,737 | -73.3% | 0.00% | – |
| Q2 2018 | $228,000 | -40.8% | 40,287 | +29.6% | 0.00% | – |
| Q1 2018 | $385,000 | -41.0% | 31,086 | -42.5% | 0.00% | – |
| Q4 2017 | $653,000 | – | 54,032 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| 5AM Venture Management, LLC | 3,831,474 | $20,268,000 | 6.83% |
| AIGH Capital Management LLC | 637,322 | $3,372,000 | 1.37% |
| Worth Venture Partners, LLC | 162,875 | $862,000 | 0.68% |
| Ikarian Capital, LLC | 1,466,147 | $7,756,000 | 0.34% |
| RA Capital Management | 3,518,998 | $18,615,000 | 0.26% |
| Orbimed Advisors | 4,797,148 | $25,377,000 | 0.22% |
| DAFNA Capital Management LLC | 38,891 | $206,000 | 0.06% |
| BOOTHBAY FUND MANAGEMENT, LLC | 150,699 | $797,000 | 0.03% |
| Alyeska Investment Group, L.P. | 355,690 | $1,882,000 | 0.03% |
| ALGERT GLOBAL LLC | 13,860 | $73,000 | 0.02% |